The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

New Evista Generic Approved: Raloxifene

by The GoodRx Pharmacist on March 10, 2014 at 10:34 am

The FDA has approved raloxifene (generic Evista) as of March 2014. Brand name Evista was first approved in 1997.

The generic pharmaceutical manufacturer of raloxifene, TEVA, will be granted marketing exclusivity for 180 days and will begin to ship raloxifene within the next 30 days.

Who and what is this medication for?
Raloxifene is indicated in postmenopausal women for the treatment and prevention of osteoporosis, and it reduces the risk of invasive breast cancer in women with osteoporosis or others who are at high risk.

Who should NOT use raloxifene?
Raloxifene should NOT be used in pregnant or breast-feeding women, or in women with a history of or with active venous thromboembolisms (AKA blood clots).

How is raloxifene usually taken?
Raloxifene should be taken as 1 tablet once daily.

If I am using this medication for osteoporosis is there anything important I should know?

Yes. Evista or raloxifene, if used for the prevention or treatment of osteoporosis, should be taken with a supplemental calcium/vitamin D product if you aren’t getting a sufficient amount though diet alone.

For more information on Evista (raloxifene), check out the Evista package insert here.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.